Sino BiopharmaceuticalSBMFF -4.96%62 Interest Coverage is 22.26 as of Dec. 2025, which is 1% above its 10-year median of 22.04. GuruFocus rates SBMFF with a GF Score™ of 62/100 and a GF Value™ of $0.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 377 Biotechnology companies, Sino Biopharmaceutical ranks worse than 65.52% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sino Biopharmaceutical's
Operating Income
for the
six
months ended in Dec. 2025 was $490 Mil. Sino Biopharmaceutical's Interest Expense for the
six
months ended in Dec. 2025 was $-22 Mil.
Sino Biopharmaceutical's interest coverage for the quarter that ended in Dec. 2025 was 22.26.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sino Biopharmaceutical's Interest Coverage or its related term are showing as below:
SBMFF'
s Interest Coverage Range Over the Past 10 Years
Min: 12.29 Med: 22.04 Max: 41.86
Current: 24.78
SBMFF's Interest Coverage is ranked worse than 65.52% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs SBMFF: 24.78
Sino Biopharmaceutical (OTCPK:SBMFF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sino Biopharmaceutical Interest Coverage Related Terms
Sino Biopharmaceutical Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sino Biopharmaceutical's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SBMFF vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Sino Biopharmaceutical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Biopharmaceutical Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sino Biopharmaceutical's Interest Coverage falls into.
Sino Biopharmaceutical Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Biopharmaceutical (SBMFF) has a Interest Coverage of 22.26 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sino Biopharmaceutical and its competitors. This is near median its historical median of 22.04. Over the past decade, Sino Biopharmaceutical's Interest Coverage has ranged from 12.29 to 41.86. According to the industry distribution chart, Sino Biopharmaceutical ranks #247 out of 377 companies in the Biotechnology industry, placing it in the top 65.5%.
Is Sino Biopharmaceutical's Interest Coverage too high?
Sino Biopharmaceutical's current Interest Coverage of 22.26 is near median its 10-year median of 22.04. Over the past 10 years, this metric has ranged from a low of 12.29 to a high of 41.86. The Biotechnology industry median Interest Coverage is 106.07. Sino Biopharmaceutical's value of 22.26 is 79% below this industry median. Based on the distribution chart, Sino Biopharmaceutical ranks #247 out of 377 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sino Biopharmaceutical has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sino Biopharmaceutical's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sino Biopharmaceutical ranks #247 out of 377 companies for Interest Coverage. This places Sino Biopharmaceutical in the lower half of its industry. The industry median Interest Coverage is 106.07. Sino Biopharmaceutical's value of 22.26 is 79% below this benchmark. Historically, Sino Biopharmaceutical's own Interest Coverage has ranged from 12.29 to 41.86 over the past decade. While the company's 10-year median is 22.04 vs. the industry median of 106.07, Sino Biopharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Biopharmaceutical's current Interest Coverage of 22.26 is 79% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sino Biopharmaceutical and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Biopharmaceutical's current Interest Coverage is 22.26, which is near median its own 10-year median of 22.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Biopharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Sino Biopharmaceutical (SBMFF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.67, compared to a current price of $0.60 — trading 10.2% below its estimated fair value. The current Interest Coverage is 22.26, which is near median its 10-year median of 22.04 and 79% below the Biotechnology industry median of 106.07. Sino Biopharmaceutical's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sino Biopharmaceutical (SBMFF), the current Interest Coverage is 22.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued.
The current stock price of $0.60 is trading 10.2% below its estimated GF Value™ of $0.67.
GuruFocus considers Sino Biopharmaceutical to be Modestly Undervalued.
Key valuation signals for SBMFF:
Interest Coverage: 22.26 (near median its 10-year median of 22.04)
GF Value™: $0.67 vs. price of $0.60 (10.2% below fair value)
Industry Position: 79% below the Biotechnology median (#247 of 377)
No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
62GF Score
Get the complete analysis for SBMFF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBMFF has been successfully added to your 
